Lucena, Flávia CamposLage, Eura MartinsTeixeira, Patrícia GonçalvesBarbosa, Alexandre SimõesDiniz, Rejane SilvaLwaleed, BashirSilva, André Talvani Pedrosa daAlpoim, Patrícia NessrallaPerucci, Luiza OliveiraDusse, Luci Maria Sant'Ana2020-03-112020-03-112019LUCENA, F. C. et al. Longitudinal assessment of D-dimer and plasminogen activator inhibitor type-1 plasma levels in pregnant women with risk factors for preeclampsia. Hypertension in Pregnancy, v. 13, p. 1-6, fev. 2019. Disponível em: <https://www.tandfonline.com/doi/abs/10.1080/10641955.2019.1577435?journalCode=ihip20>. Acesso em: 10 fev. 2020.1525-6065http://www.repositorio.ufop.br/handle/123456789/11980Objective: Investigating D-Dimer/D-Di and plasminogen activator inhibitor type-1/PAI-1 levels throughout gestation in women with preeclampsia/PE risk factors. Methods: D-Di and PAI-1 plasma levels were determined in 28 women at 12–19, 20–29, 30–34 and 35–40 weeks of gestation. Results: D-Di was lower at 12–19 weeks and higher at 30–34 weeks in women who developed PE versus who did not develop it. D-Di increased throughout gestation in both groups, peaking earlier in pregnant women who developed PE versus who did not develop it. PA1-1 increased across gestation, but it didn’t differ between groups. Conclusion: D-Di was able to discriminate these groups of women at 12–19 and 30–34 weeks of gestation.en-USrestritoHypercoagulabilityArtigo publicado em periodicohttps://www.tandfonline.com/doi/abs/10.1080/10641955.2019.1577435?journalCode=ihip20https://doi.org/10.1080/10641955.2019.1577435